Global Non-animal Type Hard Capsules Market Research Report 2023
The global Non-animal Type Hard Capsules market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
According to QYResearch’s new survey, global Non-animal Type Hard Capsules market is projected to reach US$ 1408.4 million in 2029, increasing from US$ 1005.4 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-animal Type Hard Capsules market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 223%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-animal Type Hard Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Non-animal Type Hard Capsules market is projected to reach US$ 1408.4 million in 2029, increasing from US$ 1005.4 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-animal Type Hard Capsules market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 223%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-animal Type Hard Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Lonza
- Catalent
- ACG Associated Capsules
- Qualicaps (Mitsubishi Chemical)
- Bahrain Pharma
- JC Biological Technology
- CapsCanada
- Medicaps
- Aenova
- Patheon (Banner Pharmacaps)
- Roxlor
- Sunil Healthcare
- Arab-Caps
- Jedco International Pharmaceutical
- Pharco
- ACPL
- Hunan Er-Kang Pharmaceutical Co., Ltd
- Procaps S.A
- Type I
- 00E
- 0E
- Pharmaceutical
- Nutraceutical
- Cosmetics
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 NON-ANIMAL TYPE HARD CAPSULES MARKET OVERVIEW
1.1 Product Overview and Scope of Non-animal Type Hard Capsules
1.2 Non-animal Type Hard Capsules Segment by Type
1.2.1 Global Non-animal Type Hard Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Type I
1.2.3 00E
1.2.4 0E
1.3 Non-animal Type Hard Capsules Segment by Application
1.3.1 Global Non-animal Type Hard Capsules Market Value by Application: (2023-2029)
1.3.2 Pharmaceutical
1.3.3 Nutraceutical
1.3.4 Cosmetics
1.4 Global Non-animal Type Hard Capsules Market Size Estimates and Forecasts
1.4.1 Global Non-animal Type Hard Capsules Revenue 2018-2029
1.4.2 Global Non-animal Type Hard Capsules Sales 2018-2029
1.4.3 Global Non-animal Type Hard Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NON-ANIMAL TYPE HARD CAPSULES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-animal Type Hard Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-animal Type Hard Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Non-animal Type Hard Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-animal Type Hard Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-animal Type Hard Capsules, Product Type & Application
2.7 Non-animal Type Hard Capsules Market Competitive Situation and Trends
2.7.1 Non-animal Type Hard Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-animal Type Hard Capsules Players Market Share by Revenue
2.7.3 Global Non-animal Type Hard Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NON-ANIMAL TYPE HARD CAPSULES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Non-animal Type Hard Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-animal Type Hard Capsules Global Non-animal Type Hard Capsules Sales by Region: 2018-2029
3.2.1 Global Non-animal Type Hard Capsules Sales by Region: 2018-2023
3.2.2 Global Non-animal Type Hard Capsules Sales by Region: 2024-2029
3.3 Global Non-animal Type Hard Capsules Global Non-animal Type Hard Capsules Revenue by Region: 2018-2029
3.3.1 Global Non-animal Type Hard Capsules Revenue by Region: 2018-2023
3.3.2 Global Non-animal Type Hard Capsules Revenue by Region: 2024-2029
3.4 North America Non-animal Type Hard Capsules Market Facts & Figures by Country
3.4.1 North America Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.4.3 North America Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-animal Type Hard Capsules Market Facts & Figures by Country
3.5.1 Europe Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.5.3 Europe Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-animal Type Hard Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-animal Type Hard Capsules Market Facts & Figures by Country
3.7.1 Latin America Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.7.3 Latin America Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-animal Type Hard Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 SEGMENT BY TYPE
4.1 Global Non-animal Type Hard Capsules Sales by Type (2018-2029)
4.1.1 Global Non-animal Type Hard Capsules Sales by Type (2018-2023)
4.1.2 Global Non-animal Type Hard Capsules Sales by Type (2024-2029)
4.1.3 Global Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
4.2 Global Non-animal Type Hard Capsules Revenue by Type (2018-2029)
4.2.1 Global Non-animal Type Hard Capsules Revenue by Type (2018-2023)
4.2.2 Global Non-animal Type Hard Capsules Revenue by Type (2024-2029)
4.2.3 Global Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Non-animal Type Hard Capsules Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Non-animal Type Hard Capsules Sales by Application (2018-2029)
5.1.1 Global Non-animal Type Hard Capsules Sales by Application (2018-2023)
5.1.2 Global Non-animal Type Hard Capsules Sales by Application (2024-2029)
5.1.3 Global Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
5.2 Global Non-animal Type Hard Capsules Revenue by Application (2018-2029)
5.2.1 Global Non-animal Type Hard Capsules Revenue by Application (2018-2023)
5.2.2 Global Non-animal Type Hard Capsules Revenue by Application (2024-2029)
5.2.3 Global Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Non-animal Type Hard Capsules Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Lonza
6.1.1 Lonza Corporation Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Lonza Non-animal Type Hard Capsules Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Catalent
6.2.1 Catalent Corporation Information
6.2.2 Catalent Description and Business Overview
6.2.3 Catalent Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Catalent Non-animal Type Hard Capsules Product Portfolio
6.2.5 Catalent Recent Developments/Updates
6.3 ACG Associated Capsules
6.3.1 ACG Associated Capsules Corporation Information
6.3.2 ACG Associated Capsules Description and Business Overview
6.3.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio
6.3.5 ACG Associated Capsules Recent Developments/Updates
6.4 Qualicaps (Mitsubishi Chemical)
6.4.1 Qualicaps (Mitsubishi Chemical) Corporation Information
6.4.2 Qualicaps (Mitsubishi Chemical) Description and Business Overview
6.4.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio
6.4.5 Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
6.5 Bahrain Pharma
6.5.1 Bahrain Pharma Corporation Information
6.5.2 Bahrain Pharma Description and Business Overview
6.5.3 Bahrain Pharma Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio
6.5.5 Bahrain Pharma Recent Developments/Updates
6.6 JC Biological Technology
6.6.1 JC Biological Technology Corporation Information
6.6.2 JC Biological Technology Description and Business Overview
6.6.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 JC Biological Technology Non-animal Type Hard Capsules Product Portfolio
6.6.5 JC Biological Technology Recent Developments/Updates
6.7 CapsCanada
6.6.1 CapsCanada Corporation Information
6.6.2 CapsCanada Description and Business Overview
6.6.3 CapsCanada Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CapsCanada Non-animal Type Hard Capsules Product Portfolio
6.7.5 CapsCanada Recent Developments/Updates
6.8 Medicaps
6.8.1 Medicaps Corporation Information
6.8.2 Medicaps Description and Business Overview
6.8.3 Medicaps Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medicaps Non-animal Type Hard Capsules Product Portfolio
6.8.5 Medicaps Recent Developments/Updates
6.9 Aenova
6.9.1 Aenova Corporation Information
6.9.2 Aenova Description and Business Overview
6.9.3 Aenova Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Aenova Non-animal Type Hard Capsules Product Portfolio
6.9.5 Aenova Recent Developments/Updates
6.10 Patheon (Banner Pharmacaps)
6.10.1 Patheon (Banner Pharmacaps) Corporation Information
6.10.2 Patheon (Banner Pharmacaps) Description and Business Overview
6.10.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio
6.10.5 Patheon (Banner Pharmacaps) Recent Developments/Updates
6.11 Roxlor
6.11.1 Roxlor Corporation Information
6.11.2 Roxlor Non-animal Type Hard Capsules Description and Business Overview
6.11.3 Roxlor Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Roxlor Non-animal Type Hard Capsules Product Portfolio
6.11.5 Roxlor Recent Developments/Updates
6.12 Sunil Healthcare
6.12.1 Sunil Healthcare Corporation Information
6.12.2 Sunil Healthcare Non-animal Type Hard Capsules Description and Business Overview
6.12.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio
6.12.5 Sunil Healthcare Recent Developments/Updates
6.13 Arab-Caps
6.13.1 Arab-Caps Corporation Information
6.13.2 Arab-Caps Non-animal Type Hard Capsules Description and Business Overview
6.13.3 Arab-Caps Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Arab-Caps Non-animal Type Hard Capsules Product Portfolio
6.13.5 Arab-Caps Recent Developments/Updates
6.14 Jedco International Pharmaceutical
6.14.1 Jedco International Pharmaceutical Corporation Information
6.14.2 Jedco International Pharmaceutical Non-animal Type Hard Capsules Description and Business Overview
6.14.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio
6.14.5 Jedco International Pharmaceutical Recent Developments/Updates
6.15 Pharco
6.15.1 Pharco Corporation Information
6.15.2 Pharco Non-animal Type Hard Capsules Description and Business Overview
6.15.3 Pharco Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pharco Non-animal Type Hard Capsules Product Portfolio
6.15.5 Pharco Recent Developments/Updates
6.16 ACPL
6.16.1 ACPL Corporation Information
6.16.2 ACPL Non-animal Type Hard Capsules Description and Business Overview
6.16.3 ACPL Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ACPL Non-animal Type Hard Capsules Product Portfolio
6.16.5 ACPL Recent Developments/Updates
6.17 Hunan Er-Kang Pharmaceutical Co., Ltd
6.17.1 Hunan Er-Kang Pharmaceutical Co., Ltd Corporation Information
6.17.2 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Description and Business Overview
6.17.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio
6.17.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
6.18 Procaps S.A
6.18.1 Procaps S.A Corporation Information
6.18.2 Procaps S.A Non-animal Type Hard Capsules Description and Business Overview
6.18.3 Procaps S.A Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Procaps S.A Non-animal Type Hard Capsules Product Portfolio
6.18.5 Procaps S.A Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Non-animal Type Hard Capsules Industry Chain Analysis
7.2 Non-animal Type Hard Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-animal Type Hard Capsules Production Mode & Process
7.4 Non-animal Type Hard Capsules Sales and Marketing
7.4.1 Non-animal Type Hard Capsules Sales Channels
7.4.2 Non-animal Type Hard Capsules Distributors
7.5 Non-animal Type Hard Capsules Customers
8 NON-ANIMAL TYPE HARD CAPSULES MARKET DYNAMICS
8.1 Non-animal Type Hard Capsules Industry Trends
8.2 Non-animal Type Hard Capsules Market Drivers
8.3 Non-animal Type Hard Capsules Market Challenges
8.4 Non-animal Type Hard Capsules Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Non-animal Type Hard Capsules
1.2 Non-animal Type Hard Capsules Segment by Type
1.2.1 Global Non-animal Type Hard Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Type I
1.2.3 00E
1.2.4 0E
1.3 Non-animal Type Hard Capsules Segment by Application
1.3.1 Global Non-animal Type Hard Capsules Market Value by Application: (2023-2029)
1.3.2 Pharmaceutical
1.3.3 Nutraceutical
1.3.4 Cosmetics
1.4 Global Non-animal Type Hard Capsules Market Size Estimates and Forecasts
1.4.1 Global Non-animal Type Hard Capsules Revenue 2018-2029
1.4.2 Global Non-animal Type Hard Capsules Sales 2018-2029
1.4.3 Global Non-animal Type Hard Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NON-ANIMAL TYPE HARD CAPSULES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-animal Type Hard Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-animal Type Hard Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Non-animal Type Hard Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-animal Type Hard Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-animal Type Hard Capsules, Product Type & Application
2.7 Non-animal Type Hard Capsules Market Competitive Situation and Trends
2.7.1 Non-animal Type Hard Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-animal Type Hard Capsules Players Market Share by Revenue
2.7.3 Global Non-animal Type Hard Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NON-ANIMAL TYPE HARD CAPSULES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Non-animal Type Hard Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-animal Type Hard Capsules Global Non-animal Type Hard Capsules Sales by Region: 2018-2029
3.2.1 Global Non-animal Type Hard Capsules Sales by Region: 2018-2023
3.2.2 Global Non-animal Type Hard Capsules Sales by Region: 2024-2029
3.3 Global Non-animal Type Hard Capsules Global Non-animal Type Hard Capsules Revenue by Region: 2018-2029
3.3.1 Global Non-animal Type Hard Capsules Revenue by Region: 2018-2023
3.3.2 Global Non-animal Type Hard Capsules Revenue by Region: 2024-2029
3.4 North America Non-animal Type Hard Capsules Market Facts & Figures by Country
3.4.1 North America Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.4.3 North America Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-animal Type Hard Capsules Market Facts & Figures by Country
3.5.1 Europe Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.5.3 Europe Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-animal Type Hard Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-animal Type Hard Capsules Market Facts & Figures by Country
3.7.1 Latin America Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.7.3 Latin America Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-animal Type Hard Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-animal Type Hard Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-animal Type Hard Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-animal Type Hard Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 SEGMENT BY TYPE
4.1 Global Non-animal Type Hard Capsules Sales by Type (2018-2029)
4.1.1 Global Non-animal Type Hard Capsules Sales by Type (2018-2023)
4.1.2 Global Non-animal Type Hard Capsules Sales by Type (2024-2029)
4.1.3 Global Non-animal Type Hard Capsules Sales Market Share by Type (2018-2029)
4.2 Global Non-animal Type Hard Capsules Revenue by Type (2018-2029)
4.2.1 Global Non-animal Type Hard Capsules Revenue by Type (2018-2023)
4.2.2 Global Non-animal Type Hard Capsules Revenue by Type (2024-2029)
4.2.3 Global Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Non-animal Type Hard Capsules Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Non-animal Type Hard Capsules Sales by Application (2018-2029)
5.1.1 Global Non-animal Type Hard Capsules Sales by Application (2018-2023)
5.1.2 Global Non-animal Type Hard Capsules Sales by Application (2024-2029)
5.1.3 Global Non-animal Type Hard Capsules Sales Market Share by Application (2018-2029)
5.2 Global Non-animal Type Hard Capsules Revenue by Application (2018-2029)
5.2.1 Global Non-animal Type Hard Capsules Revenue by Application (2018-2023)
5.2.2 Global Non-animal Type Hard Capsules Revenue by Application (2024-2029)
5.2.3 Global Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Non-animal Type Hard Capsules Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Lonza
6.1.1 Lonza Corporation Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Lonza Non-animal Type Hard Capsules Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Catalent
6.2.1 Catalent Corporation Information
6.2.2 Catalent Description and Business Overview
6.2.3 Catalent Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Catalent Non-animal Type Hard Capsules Product Portfolio
6.2.5 Catalent Recent Developments/Updates
6.3 ACG Associated Capsules
6.3.1 ACG Associated Capsules Corporation Information
6.3.2 ACG Associated Capsules Description and Business Overview
6.3.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 ACG Associated Capsules Non-animal Type Hard Capsules Product Portfolio
6.3.5 ACG Associated Capsules Recent Developments/Updates
6.4 Qualicaps (Mitsubishi Chemical)
6.4.1 Qualicaps (Mitsubishi Chemical) Corporation Information
6.4.2 Qualicaps (Mitsubishi Chemical) Description and Business Overview
6.4.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Portfolio
6.4.5 Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
6.5 Bahrain Pharma
6.5.1 Bahrain Pharma Corporation Information
6.5.2 Bahrain Pharma Description and Business Overview
6.5.3 Bahrain Pharma Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bahrain Pharma Non-animal Type Hard Capsules Product Portfolio
6.5.5 Bahrain Pharma Recent Developments/Updates
6.6 JC Biological Technology
6.6.1 JC Biological Technology Corporation Information
6.6.2 JC Biological Technology Description and Business Overview
6.6.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 JC Biological Technology Non-animal Type Hard Capsules Product Portfolio
6.6.5 JC Biological Technology Recent Developments/Updates
6.7 CapsCanada
6.6.1 CapsCanada Corporation Information
6.6.2 CapsCanada Description and Business Overview
6.6.3 CapsCanada Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CapsCanada Non-animal Type Hard Capsules Product Portfolio
6.7.5 CapsCanada Recent Developments/Updates
6.8 Medicaps
6.8.1 Medicaps Corporation Information
6.8.2 Medicaps Description and Business Overview
6.8.3 Medicaps Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medicaps Non-animal Type Hard Capsules Product Portfolio
6.8.5 Medicaps Recent Developments/Updates
6.9 Aenova
6.9.1 Aenova Corporation Information
6.9.2 Aenova Description and Business Overview
6.9.3 Aenova Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Aenova Non-animal Type Hard Capsules Product Portfolio
6.9.5 Aenova Recent Developments/Updates
6.10 Patheon (Banner Pharmacaps)
6.10.1 Patheon (Banner Pharmacaps) Corporation Information
6.10.2 Patheon (Banner Pharmacaps) Description and Business Overview
6.10.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Portfolio
6.10.5 Patheon (Banner Pharmacaps) Recent Developments/Updates
6.11 Roxlor
6.11.1 Roxlor Corporation Information
6.11.2 Roxlor Non-animal Type Hard Capsules Description and Business Overview
6.11.3 Roxlor Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Roxlor Non-animal Type Hard Capsules Product Portfolio
6.11.5 Roxlor Recent Developments/Updates
6.12 Sunil Healthcare
6.12.1 Sunil Healthcare Corporation Information
6.12.2 Sunil Healthcare Non-animal Type Hard Capsules Description and Business Overview
6.12.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sunil Healthcare Non-animal Type Hard Capsules Product Portfolio
6.12.5 Sunil Healthcare Recent Developments/Updates
6.13 Arab-Caps
6.13.1 Arab-Caps Corporation Information
6.13.2 Arab-Caps Non-animal Type Hard Capsules Description and Business Overview
6.13.3 Arab-Caps Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Arab-Caps Non-animal Type Hard Capsules Product Portfolio
6.13.5 Arab-Caps Recent Developments/Updates
6.14 Jedco International Pharmaceutical
6.14.1 Jedco International Pharmaceutical Corporation Information
6.14.2 Jedco International Pharmaceutical Non-animal Type Hard Capsules Description and Business Overview
6.14.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Portfolio
6.14.5 Jedco International Pharmaceutical Recent Developments/Updates
6.15 Pharco
6.15.1 Pharco Corporation Information
6.15.2 Pharco Non-animal Type Hard Capsules Description and Business Overview
6.15.3 Pharco Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Pharco Non-animal Type Hard Capsules Product Portfolio
6.15.5 Pharco Recent Developments/Updates
6.16 ACPL
6.16.1 ACPL Corporation Information
6.16.2 ACPL Non-animal Type Hard Capsules Description and Business Overview
6.16.3 ACPL Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.16.4 ACPL Non-animal Type Hard Capsules Product Portfolio
6.16.5 ACPL Recent Developments/Updates
6.17 Hunan Er-Kang Pharmaceutical Co., Ltd
6.17.1 Hunan Er-Kang Pharmaceutical Co., Ltd Corporation Information
6.17.2 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Description and Business Overview
6.17.3 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product Portfolio
6.17.5 Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
6.18 Procaps S.A
6.18.1 Procaps S.A Corporation Information
6.18.2 Procaps S.A Non-animal Type Hard Capsules Description and Business Overview
6.18.3 Procaps S.A Non-animal Type Hard Capsules Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Procaps S.A Non-animal Type Hard Capsules Product Portfolio
6.18.5 Procaps S.A Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Non-animal Type Hard Capsules Industry Chain Analysis
7.2 Non-animal Type Hard Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-animal Type Hard Capsules Production Mode & Process
7.4 Non-animal Type Hard Capsules Sales and Marketing
7.4.1 Non-animal Type Hard Capsules Sales Channels
7.4.2 Non-animal Type Hard Capsules Distributors
7.5 Non-animal Type Hard Capsules Customers
8 NON-ANIMAL TYPE HARD CAPSULES MARKET DYNAMICS
8.1 Non-animal Type Hard Capsules Industry Trends
8.2 Non-animal Type Hard Capsules Market Drivers
8.3 Non-animal Type Hard Capsules Market Challenges
8.4 Non-animal Type Hard Capsules Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Non-animal Type Hard Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Non-animal Type Hard Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Non-animal Type Hard Capsules Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-animal Type Hard Capsules Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Non-animal Type Hard Capsules Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Non-animal Type Hard Capsules Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Non-animal Type Hard Capsules, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Non-animal Type Hard Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-animal Type Hard Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Non-animal Type Hard Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-animal Type Hard Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-animal Type Hard Capsules as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-animal Type Hard Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Non-animal Type Hard Capsules Sales by Region (2018-2023) & (K Units)
Table 18. Global Non-animal Type Hard Capsules Sales Market Share by Region (2018-2023)
Table 19. Global Non-animal Type Hard Capsules Sales by Region (2024-2029) & (K Units)
Table 20. Global Non-animal Type Hard Capsules Sales Market Share by Region (2024-2029)
Table 21. Global Non-animal Type Hard Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2018-2023)
Table 23. Global Non-animal Type Hard Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2024-2029)
Table 25. North America Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 27. North America Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 28. North America Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 32. Europe Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 33. Europe Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Non-animal Type Hard Capsules Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Non-animal Type Hard Capsules Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Non-animal Type Hard Capsules Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Non-animal Type Hard Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Non-animal Type Hard Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Non-animal Type Hard Capsules Sales (K Units) by Type (2018-2023)
Table 51. Global Non-animal Type Hard Capsules Sales (K Units) by Type (2024-2029)
Table 52. Global Non-animal Type Hard Capsules Sales Market Share by Type (2018-2023)
Table 53. Global Non-animal Type Hard Capsules Sales Market Share by Type (2024-2029)
Table 54. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2023)
Table 57. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2024-2029)
Table 58. Global Non-animal Type Hard Capsules Price (USD/Unit) by Type (2018-2023)
Table 59. Global Non-animal Type Hard Capsules Price (USD/Unit) by Type (2024-2029)
Table 60. Global Non-animal Type Hard Capsules Sales (K Units) by Application (2018-2023)
Table 61. Global Non-animal Type Hard Capsules Sales (K Units) by Application (2024-2029)
Table 62. Global Non-animal Type Hard Capsules Sales Market Share by Application (2018-2023)
Table 63. Global Non-animal Type Hard Capsules Sales Market Share by Application (2024-2029)
Table 64. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2023)
Table 67. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2024-2029)
Table 68. Global Non-animal Type Hard Capsules Price (USD/Unit) by Application (2018-2023)
Table 69. Global Non-animal Type Hard Capsules Price (USD/Unit) by Application (2024-2029)
Table 70. Lonza Corporation Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Lonza Non-animal Type Hard Capsules Product
Table 74. Lonza Recent Developments/Updates
Table 75. Catalent Corporation Information
Table 76. Catalent Description and Business Overview
Table 77. Catalent Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Catalent Non-animal Type Hard Capsules Product
Table 79. Catalent Recent Developments/Updates
Table 80. ACG Associated Capsules Corporation Information
Table 81. ACG Associated Capsules Description and Business Overview
Table 82. ACG Associated Capsules Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. ACG Associated Capsules Non-animal Type Hard Capsules Product
Table 84. ACG Associated Capsules Recent Developments/Updates
Table 85. Qualicaps (Mitsubishi Chemical) Corporation Information
Table 86. Qualicaps (Mitsubishi Chemical) Description and Business Overview
Table 87. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product
Table 89. Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
Table 90. Bahrain Pharma Corporation Information
Table 91. Bahrain Pharma Description and Business Overview
Table 92. Bahrain Pharma Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Bahrain Pharma Non-animal Type Hard Capsules Product
Table 94. Bahrain Pharma Recent Developments/Updates
Table 95. JC Biological Technology Corporation Information
Table 96. JC Biological Technology Description and Business Overview
Table 97. JC Biological Technology Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. JC Biological Technology Non-animal Type Hard Capsules Product
Table 99. JC Biological Technology Recent Developments/Updates
Table 100. CapsCanada Corporation Information
Table 101. CapsCanada Description and Business Overview
Table 102. CapsCanada Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. CapsCanada Non-animal Type Hard Capsules Product
Table 104. CapsCanada Recent Developments/Updates
Table 105. Medicaps Corporation Information
Table 106. Medicaps Description and Business Overview
Table 107. Medicaps Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Medicaps Non-animal Type Hard Capsules Product
Table 109. Medicaps Recent Developments/Updates
Table 110. Aenova Corporation Information
Table 111. Aenova Description and Business Overview
Table 112. Aenova Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Aenova Non-animal Type Hard Capsules Product
Table 114. Aenova Recent Developments/Updates
Table 115. Patheon (Banner Pharmacaps) Corporation Information
Table 116. Patheon (Banner Pharmacaps) Description and Business Overview
Table 117. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product
Table 119. Patheon (Banner Pharmacaps) Recent Developments/Updates
Table 120. Roxlor Corporation Information
Table 121. Roxlor Description and Business Overview
Table 122. Roxlor Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Roxlor Non-animal Type Hard Capsules Product
Table 124. Roxlor Recent Developments/Updates
Table 125. Sunil Healthcare Corporation Information
Table 126. Sunil Healthcare Description and Business Overview
Table 127. Sunil Healthcare Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Sunil Healthcare Non-animal Type Hard Capsules Product
Table 129. Sunil Healthcare Recent Developments/Updates
Table 130. Arab-Caps Corporation Information
Table 131. Arab-Caps Description and Business Overview
Table 132. Arab-Caps Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Arab-Caps Non-animal Type Hard Capsules Product
Table 134. Arab-Caps Recent Developments/Updates
Table 135. Jedco International Pharmaceutical Corporation Information
Table 136. Jedco International Pharmaceutical Description and Business Overview
Table 137. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product
Table 139. Jedco International Pharmaceutical Recent Developments/Updates
Table 140. Pharco Corporation Information
Table 141. Pharco Description and Business Overview
Table 142. Pharco Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Pharco Non-animal Type Hard Capsules Product
Table 144. Pharco Recent Developments/Updates
Table 145. ACPL Corporation Information
Table 146. ACPL Description and Business Overview
Table 147. ACPL Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. ACPL Non-animal Type Hard Capsules Product
Table 149. ACPL Recent Developments/Updates
Table 150. Hunan Er-Kang Pharmaceutical Co., Ltd Corporation Information
Table 151. Hunan Er-Kang Pharmaceutical Co., Ltd Description and Business Overview
Table 152. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product
Table 154. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 155. Procaps S.A Corporation Information
Table 156. Procaps S.A Description and Business Overview
Table 157. Procaps S.A Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Procaps S.A Non-animal Type Hard Capsules Product
Table 159. Procaps S.A Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Non-animal Type Hard Capsules Distributors List
Table 163. Non-animal Type Hard Capsules Customers List
Table 164. Non-animal Type Hard Capsules Market Trends
Table 165. Non-animal Type Hard Capsules Market Drivers
Table 166. Non-animal Type Hard Capsules Market Challenges
Table 167. Non-animal Type Hard Capsules Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 1. Global Non-animal Type Hard Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Non-animal Type Hard Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Non-animal Type Hard Capsules Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-animal Type Hard Capsules Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Non-animal Type Hard Capsules Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Non-animal Type Hard Capsules Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Non-animal Type Hard Capsules Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Non-animal Type Hard Capsules, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Non-animal Type Hard Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-animal Type Hard Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Non-animal Type Hard Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-animal Type Hard Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-animal Type Hard Capsules as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-animal Type Hard Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Non-animal Type Hard Capsules Sales by Region (2018-2023) & (K Units)
Table 18. Global Non-animal Type Hard Capsules Sales Market Share by Region (2018-2023)
Table 19. Global Non-animal Type Hard Capsules Sales by Region (2024-2029) & (K Units)
Table 20. Global Non-animal Type Hard Capsules Sales Market Share by Region (2024-2029)
Table 21. Global Non-animal Type Hard Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2018-2023)
Table 23. Global Non-animal Type Hard Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Non-animal Type Hard Capsules Revenue Market Share by Region (2024-2029)
Table 25. North America Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 27. North America Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 28. North America Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 32. Europe Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 33. Europe Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Non-animal Type Hard Capsules Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Non-animal Type Hard Capsules Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Non-animal Type Hard Capsules Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Non-animal Type Hard Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Non-animal Type Hard Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Non-animal Type Hard Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Non-animal Type Hard Capsules Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Non-animal Type Hard Capsules Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Non-animal Type Hard Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non-animal Type Hard Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Non-animal Type Hard Capsules Sales (K Units) by Type (2018-2023)
Table 51. Global Non-animal Type Hard Capsules Sales (K Units) by Type (2024-2029)
Table 52. Global Non-animal Type Hard Capsules Sales Market Share by Type (2018-2023)
Table 53. Global Non-animal Type Hard Capsules Sales Market Share by Type (2024-2029)
Table 54. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2018-2023)
Table 57. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2024-2029)
Table 58. Global Non-animal Type Hard Capsules Price (USD/Unit) by Type (2018-2023)
Table 59. Global Non-animal Type Hard Capsules Price (USD/Unit) by Type (2024-2029)
Table 60. Global Non-animal Type Hard Capsules Sales (K Units) by Application (2018-2023)
Table 61. Global Non-animal Type Hard Capsules Sales (K Units) by Application (2024-2029)
Table 62. Global Non-animal Type Hard Capsules Sales Market Share by Application (2018-2023)
Table 63. Global Non-animal Type Hard Capsules Sales Market Share by Application (2024-2029)
Table 64. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Non-animal Type Hard Capsules Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2018-2023)
Table 67. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2024-2029)
Table 68. Global Non-animal Type Hard Capsules Price (USD/Unit) by Application (2018-2023)
Table 69. Global Non-animal Type Hard Capsules Price (USD/Unit) by Application (2024-2029)
Table 70. Lonza Corporation Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Lonza Non-animal Type Hard Capsules Product
Table 74. Lonza Recent Developments/Updates
Table 75. Catalent Corporation Information
Table 76. Catalent Description and Business Overview
Table 77. Catalent Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Catalent Non-animal Type Hard Capsules Product
Table 79. Catalent Recent Developments/Updates
Table 80. ACG Associated Capsules Corporation Information
Table 81. ACG Associated Capsules Description and Business Overview
Table 82. ACG Associated Capsules Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. ACG Associated Capsules Non-animal Type Hard Capsules Product
Table 84. ACG Associated Capsules Recent Developments/Updates
Table 85. Qualicaps (Mitsubishi Chemical) Corporation Information
Table 86. Qualicaps (Mitsubishi Chemical) Description and Business Overview
Table 87. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product
Table 89. Qualicaps (Mitsubishi Chemical) Recent Developments/Updates
Table 90. Bahrain Pharma Corporation Information
Table 91. Bahrain Pharma Description and Business Overview
Table 92. Bahrain Pharma Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Bahrain Pharma Non-animal Type Hard Capsules Product
Table 94. Bahrain Pharma Recent Developments/Updates
Table 95. JC Biological Technology Corporation Information
Table 96. JC Biological Technology Description and Business Overview
Table 97. JC Biological Technology Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. JC Biological Technology Non-animal Type Hard Capsules Product
Table 99. JC Biological Technology Recent Developments/Updates
Table 100. CapsCanada Corporation Information
Table 101. CapsCanada Description and Business Overview
Table 102. CapsCanada Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. CapsCanada Non-animal Type Hard Capsules Product
Table 104. CapsCanada Recent Developments/Updates
Table 105. Medicaps Corporation Information
Table 106. Medicaps Description and Business Overview
Table 107. Medicaps Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Medicaps Non-animal Type Hard Capsules Product
Table 109. Medicaps Recent Developments/Updates
Table 110. Aenova Corporation Information
Table 111. Aenova Description and Business Overview
Table 112. Aenova Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Aenova Non-animal Type Hard Capsules Product
Table 114. Aenova Recent Developments/Updates
Table 115. Patheon (Banner Pharmacaps) Corporation Information
Table 116. Patheon (Banner Pharmacaps) Description and Business Overview
Table 117. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product
Table 119. Patheon (Banner Pharmacaps) Recent Developments/Updates
Table 120. Roxlor Corporation Information
Table 121. Roxlor Description and Business Overview
Table 122. Roxlor Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Roxlor Non-animal Type Hard Capsules Product
Table 124. Roxlor Recent Developments/Updates
Table 125. Sunil Healthcare Corporation Information
Table 126. Sunil Healthcare Description and Business Overview
Table 127. Sunil Healthcare Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Sunil Healthcare Non-animal Type Hard Capsules Product
Table 129. Sunil Healthcare Recent Developments/Updates
Table 130. Arab-Caps Corporation Information
Table 131. Arab-Caps Description and Business Overview
Table 132. Arab-Caps Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Arab-Caps Non-animal Type Hard Capsules Product
Table 134. Arab-Caps Recent Developments/Updates
Table 135. Jedco International Pharmaceutical Corporation Information
Table 136. Jedco International Pharmaceutical Description and Business Overview
Table 137. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product
Table 139. Jedco International Pharmaceutical Recent Developments/Updates
Table 140. Pharco Corporation Information
Table 141. Pharco Description and Business Overview
Table 142. Pharco Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Pharco Non-animal Type Hard Capsules Product
Table 144. Pharco Recent Developments/Updates
Table 145. ACPL Corporation Information
Table 146. ACPL Description and Business Overview
Table 147. ACPL Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. ACPL Non-animal Type Hard Capsules Product
Table 149. ACPL Recent Developments/Updates
Table 150. Hunan Er-Kang Pharmaceutical Co., Ltd Corporation Information
Table 151. Hunan Er-Kang Pharmaceutical Co., Ltd Description and Business Overview
Table 152. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Hunan Er-Kang Pharmaceutical Co., Ltd Non-animal Type Hard Capsules Product
Table 154. Hunan Er-Kang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 155. Procaps S.A Corporation Information
Table 156. Procaps S.A Description and Business Overview
Table 157. Procaps S.A Non-animal Type Hard Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Procaps S.A Non-animal Type Hard Capsules Product
Table 159. Procaps S.A Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Non-animal Type Hard Capsules Distributors List
Table 163. Non-animal Type Hard Capsules Customers List
Table 164. Non-animal Type Hard Capsules Market Trends
Table 165. Non-animal Type Hard Capsules Market Drivers
Table 166. Non-animal Type Hard Capsules Market Challenges
Table 167. Non-animal Type Hard Capsules Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Non-animal Type Hard Capsules
Figure 2. Global Non-animal Type Hard Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Non-animal Type Hard Capsules Market Share by Type in 2022 & 2029
Figure 4. Type I Product Picture
Figure 5. 00E Product Picture
Figure 6. 0E Product Picture
Figure 7. Global Non-animal Type Hard Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Non-animal Type Hard Capsules Market Share by Application in 2022 & 2029
Figure 9. Pharmaceutical
Figure 10. Nutraceutical
Figure 11. Cosmetics
Figure 12. Global Non-animal Type Hard Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Non-animal Type Hard Capsules Market Size (2018-2029) & (US$ Million)
Figure 14. Global Non-animal Type Hard Capsules Sales (2018-2029) & (K Units)
Figure 15. Global Non-animal Type Hard Capsules Average Price (USD/Unit) & (2018-2029)
Figure 16. Non-animal Type Hard Capsules Report Years Considered
Figure 17. Non-animal Type Hard Capsules Sales Share by Manufacturers in 2022
Figure 18. Global Non-animal Type Hard Capsules Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Non-animal Type Hard Capsules Players: Market Share by Revenue in 2022
Figure 20. Non-animal Type Hard Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Non-animal Type Hard Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 23. North America Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 27. Europe Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 28. Germany Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Non-animal Type Hard Capsules Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Non-animal Type Hard Capsules Revenue Market Share by Region (2018-2029)
Figure 35. China Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 46. Latin America Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Non-animal Type Hard Capsules by Type (2018-2029)
Figure 56. Global Revenue Market Share of Non-animal Type Hard Capsules by Type (2018-2029)
Figure 57. Global Non-animal Type Hard Capsules Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Non-animal Type Hard Capsules by Application (2018-2029)
Figure 59. Global Revenue Market Share of Non-animal Type Hard Capsules by Application (2018-2029)
Figure 60. Global Non-animal Type Hard Capsules Price (USD/Unit) by Application (2018-2029)
Figure 61. Non-animal Type Hard Capsules Value Chain
Figure 62. Non-animal Type Hard Capsules Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Product Picture of Non-animal Type Hard Capsules
Figure 2. Global Non-animal Type Hard Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Non-animal Type Hard Capsules Market Share by Type in 2022 & 2029
Figure 4. Type I Product Picture
Figure 5. 00E Product Picture
Figure 6. 0E Product Picture
Figure 7. Global Non-animal Type Hard Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Non-animal Type Hard Capsules Market Share by Application in 2022 & 2029
Figure 9. Pharmaceutical
Figure 10. Nutraceutical
Figure 11. Cosmetics
Figure 12. Global Non-animal Type Hard Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Non-animal Type Hard Capsules Market Size (2018-2029) & (US$ Million)
Figure 14. Global Non-animal Type Hard Capsules Sales (2018-2029) & (K Units)
Figure 15. Global Non-animal Type Hard Capsules Average Price (USD/Unit) & (2018-2029)
Figure 16. Non-animal Type Hard Capsules Report Years Considered
Figure 17. Non-animal Type Hard Capsules Sales Share by Manufacturers in 2022
Figure 18. Global Non-animal Type Hard Capsules Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Non-animal Type Hard Capsules Players: Market Share by Revenue in 2022
Figure 20. Non-animal Type Hard Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Non-animal Type Hard Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 23. North America Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 27. Europe Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 28. Germany Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Non-animal Type Hard Capsules Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Non-animal Type Hard Capsules Revenue Market Share by Region (2018-2029)
Figure 35. China Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 46. Latin America Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Non-animal Type Hard Capsules Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Non-animal Type Hard Capsules Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Non-animal Type Hard Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Non-animal Type Hard Capsules by Type (2018-2029)
Figure 56. Global Revenue Market Share of Non-animal Type Hard Capsules by Type (2018-2029)
Figure 57. Global Non-animal Type Hard Capsules Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Non-animal Type Hard Capsules by Application (2018-2029)
Figure 59. Global Revenue Market Share of Non-animal Type Hard Capsules by Application (2018-2029)
Figure 60. Global Non-animal Type Hard Capsules Price (USD/Unit) by Application (2018-2029)
Figure 61. Non-animal Type Hard Capsules Value Chain
Figure 62. Non-animal Type Hard Capsules Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
